Envestnet Asset Management
RYTM icon

Envestnet Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Envestnet Asset Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$418K Buy
+3,769
New +$341K ﹤0.01% 4217

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Envestnet Asset Management's RYTM Position: Q2 2026 in Review

Envestnet Asset Management opened a new position in Rhythm Pharmaceuticals (RYTM) in Q2 2026: 3,769 shares worth $418K. The stake represents ﹤0.01% of the portfolio and ranks #4217 among its holdings.

305 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Envestnet Asset Management held 3,769 shares of Rhythm Pharmaceuticals worth $418K as of Q2 2026.
  • Rhythm Pharmaceuticals was a new Envestnet Asset Management position in Q2 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #4217 holding.
  • 305 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.